Free Trial

Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) Hits New 1-Year High - Here's Why

Fresenius SE & Co. KGaA logo with Medical background

Fresenius SE & Co. KGaA (OTCMKTS:FSNUY - Get Free Report)'s stock price reached a new 52-week high during trading on Friday . The company traded as high as $9.84 and last traded at $9.65, with a volume of 32902 shares changing hands. The stock had previously closed at $9.61.

Wall Street Analysts Forecast Growth

Separately, Citigroup raised Fresenius SE & Co. KGaA to a "strong-buy" rating in a research note on Friday, October 25th.

View Our Latest Report on FSNUY

Fresenius SE & Co. KGaA Trading Up 0.4 %

The firm's 50-day moving average price is $8.91 and its 200-day moving average price is $8.96. The company has a current ratio of 1.36, a quick ratio of 1.05 and a debt-to-equity ratio of 0.57.

Fresenius SE & Co. KGaA (OTCMKTS:FSNUY - Get Free Report) last released its quarterly earnings results on Wednesday, November 6th. The company reported $0.19 earnings per share for the quarter. The firm had revenue of $5.90 billion for the quarter. As a group, analysts anticipate that Fresenius SE & Co. KGaA will post 0.79 earnings per share for the current fiscal year.

Fresenius SE & Co. KGaA Company Profile

(Get Free Report)

Fresenius SE & Co KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure.

Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Fresenius SE & Co. KGaA Right Now?

Before you consider Fresenius SE & Co. KGaA, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Fresenius SE & Co. KGaA wasn't on the list.

While Fresenius SE & Co. KGaA currently has a "Strong Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings: Will it Spark a Rally or Trigger a Sell-Off?
Marjorie Taylor Greene Bought THOUSANDS in Tesla Stock
The EXACT Date of Next Stock Market Crash

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines